Core Viewpoint - ASMPT's third-quarter performance was generally below expectations due to profit reduction and restructuring costs, but management provided a positive outlook for the fourth quarter with expected sales of $470 million to $530 million, representing a 7% quarter-over-quarter increase and a 14% year-over-year increase [1] Financial Performance - ASMPT's third-quarter results were impacted by profit shrinkage and restructuring expenses, leading to performance that fell short of expectations [1] - The company anticipates strong earnings growth for the next year, with projections indicating that earnings per share could more than double due to a low base in 2025, although revenue and profit levels are expected to remain at moderate cyclical levels [1] Analyst Rating - The firm reiterated a "neutral" rating on ASMPT, adjusting the target price from HKD 100 to HKD 95 [1]
美银证券:降ASMPT(00522)目标价至95港元 重申“中性”评级